Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombotic Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04735588
What this trial is testing

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

Who this might be right for
Immune ThrombocytopeniaITPCovid19+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 140
Not applicableEnded earlyNCT01386723
What this trial is testing

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 35
Not applicableUnknownNCT04214951
What this trial is testing

Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)UnknownNCT03692754
What this trial is testing

Atorvastatin in Management of Newly Diagnosed ITP

Who this might be right for
Immune ThrombocytopeniaPurpura, Thrombocytopenic
Shandong University 30
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Early research (Phase 1)Looking for participantsNCT06880081
What this trial is testing

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)UnknownNCT04588194
What this trial is testing

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic Purpura
David Gomez Almaguer 12
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Not applicableWithdrawnNCT01317966
What this trial is testing

Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ming Hou
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Not applicableStudy completedNCT04057703
What this trial is testing

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune Hemolytic AnemiaEvan Syndrome+1 more
University Hospital, Bordeaux 454
Not applicableLooking for participantsNCT06919341
What this trial is testing

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Who this might be right for
ITP - Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía 1,000
Large-scale testing (Phase 3)Study completedNCT03010202
What this trial is testing

The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ostfold Hospital Trust 136
Not applicableNot Yet RecruitingNCT07798050
What this trial is testing

Selective Mediterranean Diet in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraThrombocytopenia
Assiut University 60
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Large-scale testing (Phase 3)Study completedNCT02076412
What this trial is testing

A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 74
Not applicableLooking for participantsNCT07612319
What this trial is testing

Romiplostim for Oral TPO-RA Resistant ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Next Page